{4-[(2-{3-[(2R)-3-[({[({[(2S,3R,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-3-(phosphonooxy)oxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)methyl]-2-hydroxy-3-methylbutanamido]propanamido}ethyl)sulfanyl]-4-oxobutyl}(hydroxy)-oxo-$l^{5}-azanyl

• ChemBase编号: 2942
• 分子式: C25H42N8O19P3S
• 平均质量: 883.629463
• 单一同位素质量: 883.14997705
• SMILES: CC(C)(CO[P@@](=O)(O)O[P@](=O)(O)OC[C@@H]1O[C@H]([C@H](O)[C@H]1OP(=O)(O)O)n1cnc2c1ncnc2N)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)CCC[N](=O)O
• Canonical SMILES: O=C(NCCSC(=O)CCC[N](=O)O)CCNC(=O)[C@@H](C(CO[P@](=O)(O[P@@](=O)(OC[C@@H]1O[C@H]([C@@H]([C@H]1OP(=O)(O)O)O)n1cnc2c1ncnc2N)O)O)(C)C)O
• InChI: InChI=1S/C25H42N8O19P3S/c1-25(2,20(37)23(38)28-6-5-15(34)27-7-9-56-16(35)4-3-8-33(39)40)11-49-55(46,47)52-54(44,45)48-10-14-19(51-53(41,42)43)18(36)24(50-14)32-13-31-17-21(26)29-12-30-22(17)32/h12-14,18-20,24,36-37H,3-11H2,1-2H3,(H,27,34)(H,28,38)(H,39,40)(H,44,45)(H,46,47)(H2,26,29,30)(H2,41,42,43)/t14-,18+,19-,20-,24+/m0/s1
• InChIKey: LXDJZADOCCLHJS-NEQUNHHKSA-N

名称和登记号

名称

• IUPAC标准名: {4-[(2-{3-[(2R)-3-[({[({[(2S,3R,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-3-(phosphonooxy)oxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)methyl]-2-hydroxy-3-methylbutanamido]propanamido}ethyl)sulfanyl]-4-oxobutyl}(hydroxy)-oxo-$l^{5}-azanyl
• IUPAC传统名: 4-[(2-{3-[(2R)-3-{[({[(2S,3R,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-(phosphonooxy)oxolan-2-yl]methoxy(hydroxy)phosphoryl}oxy(hydroxy)phosphoryl)oxy]methyl}-2-hydroxy-3-methylbutanamido]propanamido}ethyl)sulfanyl]-4-oxobutyl(hydroxy)-oxo-$l^{5}-azanyl
• 别名: S-4-Nitrobutyryl-Coa

登记号

• PubChem SID: 160966389; 46505726
• PubChem CID: 0

理论计算性质

JChem

• 质子受体: 0
• 质子供体: 0
• 摩尔折射率: 187.8084 cm^3
• 极化表面积: 420.14 Å^2
• 可自由旋转的化学键: 24
• 里宾斯基五规则: false

ALOGPS 2.1

• Log P: 1.84
• LOG S: -2.39
• 溶解度: 3.64e+00 g/l

详细说明

DrugBank - DB03245

Drug information: experimental